NVO’s Ryzodeg Approved in Japan (LLY) (MRK) (NVO) (SNY)
Denmark based Novo Nordisk ( NVO ) recently announced that it has received approval in Japan for its diabetes treatment, Ryzodeg (insulin degludec/insulin aspart). Ryzodeg was submitted for regulatory approval to the Japanese Ministry of Health, Labour and Welfare in March 2012. […]